CTX130 Allogeneic CRISPR-Cas9-engineered Chimeric Antigen Receptor (CAR) T Cells in Patients with Advanced Clear Cell Renal Cell Carcinoma: Long-term Follow-Up and Translational Data from the Phase 1 COBALT-RCC Study

CANCER RESEARCH(2024)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要